Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

Arun J. Sanyal*, Vlad Ratziu, Rohit Loomba, Quentin M. Anstee, Kris V. Kowdley, Mary E. Rinella, Muhammed Y Sheikh, James F. Trotter, Whitfield Knapple, Eric J Lawitz, Manal F. Abdelmalek, Philip N. Newsome, Jérôme Boursier, Philippe Mathurin, Jean-François Dufour, M. Michelle Berrey, Steven J. Shiff, Sangeeta Sawhney, Thomas Capozza, Rina LeyvaStephen A. Harrison, Zobair M. Younossi

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

54 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis'. Together they form a unique fingerprint.

Medicine & Life Sciences